Fremanezumab: A Safe Choice for Migraine Prevention
- MigraineMind
- Dec 7, 2025
- 1 min read
Research Summary
A recent study published in Expert Opinion on Drug Safety evaluates the safety and tolerability of fremanezumab, a medication for migraine prevention. The research highlights that fremanezumab is generally well-tolerated, with adverse events being mostly mild to moderate. The most common side effect reported was injection site reactions, occurring in 43% of patients. The study underscores fremanezumab's promising safety profile, making it a viable option for those seeking migraine prevention. These findings provide reassurance for patients and healthcare providers considering fremanezumab as part of a migraine management plan, emphasizing its potential to improve quality of life for sufferers.
Study Details
👥 Research Team: Hoehne CL, Raffaelli B
📚 Published In: Expert Opin Drug Saf
📅 Publication Date: 2025 Dec 6
⚕️ Medical Disclaimer: This summary is generated automatically from recent migraine research. Always consult with healthcare professionals for medical advice.